PLN 184.4
(-1.91%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 297.32 Million PLN | 25.73% |
2022 | 236.48 Million PLN | 48.09% |
2021 | 159.68 Million PLN | 12.76% |
2020 | 141.61 Million PLN | 13.2% |
2019 | 125.09 Million PLN | 15.2% |
2018 | 108.58 Million PLN | -5.77% |
2017 | 115.23 Million PLN | 26.97% |
2016 | 90.75 Million PLN | -13.08% |
2015 | 104.4 Million PLN | -2.24% |
2014 | 106.79 Million PLN | 1.6% |
2013 | 105.11 Million PLN | 70.74% |
2012 | 61.56 Million PLN | 21.99% |
2011 | 50.46 Million PLN | 304.05% |
2010 | 12.49 Million PLN | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 322.54 Million PLN | -18.87% |
2024 Q3 | 350.55 Million PLN | 8.68% |
2024 Q1 | 397.56 Million PLN | 33.72% |
2023 Q3 | 259.91 Million PLN | 8.18% |
2023 Q1 | 234.18 Million PLN | -0.97% |
2023 Q2 | 240.26 Million PLN | 2.6% |
2023 FY | 297.32 Million PLN | 25.73% |
2023 Q4 | 297.32 Million PLN | 14.39% |
2022 Q1 | 165.95 Million PLN | 3.93% |
2022 Q4 | 236.48 Million PLN | 16.88% |
2022 Q3 | 202.32 Million PLN | 0.92% |
2022 Q2 | 200.46 Million PLN | 20.8% |
2022 FY | 236.48 Million PLN | 48.09% |
2021 Q2 | 134.7 Million PLN | -5.36% |
2021 FY | 159.68 Million PLN | 12.76% |
2021 Q4 | 159.68 Million PLN | 17.7% |
2021 Q3 | 135.67 Million PLN | 0.72% |
2021 Q1 | 142.33 Million PLN | 0.51% |
2020 Q1 | 149.04 Million PLN | 19.15% |
2020 Q4 | 141.61 Million PLN | 17.38% |
2020 Q3 | 120.64 Million PLN | -14.11% |
2020 Q2 | 140.46 Million PLN | -5.76% |
2020 FY | 141.61 Million PLN | 13.2% |
2019 Q2 | 121.68 Million PLN | -22.34% |
2019 Q3 | 112.11 Million PLN | -7.86% |
2019 Q1 | 156.69 Million PLN | 21.2% |
2019 Q4 | 125.09 Million PLN | 11.57% |
2019 FY | 125.09 Million PLN | 15.2% |
2018 Q4 | 129.28 Million PLN | 8.01% |
2018 FY | 108.58 Million PLN | -5.77% |
2018 Q3 | 119.69 Million PLN | 0.44% |
2018 Q1 | 119.17 Million PLN | 21.18% |
2018 Q2 | 119.17 Million PLN | 0.0% |
2017 Q4 | 98.34 Million PLN | 10.59% |
2017 FY | 115.23 Million PLN | 26.97% |
2017 Q2 | 86.5 Million PLN | -4.68% |
2017 Q3 | 88.93 Million PLN | 2.8% |
2017 Q1 | 90.75 Million PLN | -2.52% |
2016 Q4 | 93.09 Million PLN | 3.86% |
2016 Q3 | 89.63 Million PLN | 0.76% |
2016 Q1 | 104.4 Million PLN | -2.86% |
2016 FY | 90.75 Million PLN | -13.08% |
2016 Q2 | 88.96 Million PLN | -14.79% |
2015 Q4 | 107.47 Million PLN | 35.62% |
2015 Q1 | 106.79 Million PLN | 3.46% |
2015 FY | 104.4 Million PLN | -2.24% |
2015 Q3 | 79.24 Million PLN | -14.07% |
2015 Q2 | 92.22 Million PLN | -13.65% |
2014 Q1 | 105.11 Million PLN | 55.39% |
2014 Q3 | 99.37 Million PLN | 4.37% |
2014 Q2 | 95.21 Million PLN | -9.42% |
2014 FY | 106.79 Million PLN | 1.6% |
2014 Q4 | 103.21 Million PLN | 3.87% |
2013 Q2 | 51.59 Million PLN | -16.19% |
2013 Q4 | 67.64 Million PLN | 43.28% |
2013 Q1 | 61.56 Million PLN | 36.23% |
2013 FY | 105.11 Million PLN | 70.74% |
2013 Q3 | 47.21 Million PLN | -8.5% |
2012 FY | 61.56 Million PLN | 21.99% |
2012 Q4 | 45.19 Million PLN | 16.23% |
2012 Q3 | 38.88 Million PLN | -9.46% |
2012 Q2 | 42.94 Million PLN | 0.0% |
2011 FY | 50.46 Million PLN | 304.05% |
2010 FY | 12.49 Million PLN | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Adiuvo Investments S.A. | 2.2 Million PLN | -13377.886% |
Genomtec S.A. | 16.04 Million PLN | -1752.705% |
Medinice S.A. | 37.49 Million PLN | -693.007% |
Medicalgorithmics S.A. | 121.63 Million PLN | -144.446% |